IP Library › Assignment 075601/0687
Patent Assignment
Reel/Frame 075601/0687

Release of Security Interest (Reel 070494, Frame 0042)

Recorded: 2026-05-19 Pages: 9
Assignor
Assignees
SOLENO THERAPEUTICS, INC.
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CALIFORNIA, 94065
ESSENTIALIS, INC.
100 MARINE PARKWAY, SUITE 400, REDWOOD CITY, CALIFORNIA, 94065
Covered Properties (16)
Methods for Treating Subjects with Prader-Willi Syndrome or Smith-Magenis Syndrome
Application: 15/671,792 →
Publication: US US20180021344A1
Salts of Potassium Atp Channel Openers and Uses Thereof
Application: 15/195,826 →
Publication: US US20170143732A1
Methods for Treating Subjects with Prader-Willi Syndrome or Smith-Magenis Syndrome
Application: 16/041,237 →
Publication: US US20190105327A1
Methods for Treating Subjects with Prader-Willi Syndrome or Smith-Magenis Syndrome
Application: 16/573,965 →
Publication: US US20200147100A1
Salts of Potassium Atp Channel Openers and Uses Thereof
Application: 16/680,093 →
Publication: US US20200222417A1
Salts of Potassium Atp Channel Openers and Uses Thereof
Application: 17/332,878 →
Publication: US US20220047605A1
Salts of Potassium Atp Channel Openers and Uses Thereof
Patent: 7,572,789 →
Application: 12/391,990 →
Publication: US US20090148526A1
Salts of Potassium Atp Channel Openers and Uses Thereof
Patent: 7,799,777 →
Application: 11/614,044 →
Publication: US US20070191351A1
Salts of Potassium Atp Channel Openers and Uses Thereof
Patent: 9,381,202 →
Application: 13/846,542 →
Publication: US US20130225806A1
Methods for Treating Subjects with Prader-Willi Syndrome or Smith-Magenis Syndrome
Patent: 9,757,384 →
Application: 14/940,018 →
Publication: US US20160136178A1
Salts of Potassium Atp Channel Openers and Uses Thereof
Patent: 9,765,043 →
Application: 14/466,852 →
Publication: US US20140364425A1
Pharmaceutical Formulations of Potassium Atp Channel Openers and Uses Thereof
Patent: 9,782,416 →
Application: 14/458,032 →
Publication: US US20140350001A1
Methods for Treating Subjects with Prader-Willi Syndrome or Smith-Magenis Syndrome
Application: 18/421,914 →
Publication: US US20240207284A1
Salts of Potassium Atp Channel Openers and Uses Thereof
Application: 18/454,595 →
Publication: US US20240252507A1
Methods for Treating Subjects with Prader-Willi Syndrome or Smith-Magenis Syndrome
Application: 18/824,811 →
Publication: US US20240423996A1
Methods for Treating Subjects with Prader-Willi Syndrome or Smith-Magenis Syndrome
Application: 18/988,636 →
Publication: US US20250120979A1
Related Assignments (22)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 25, 2007
From: COWEN, NEIL M; KASHKIN, KENNETH B; YAMOUT, KHALED A
To: ESSENTIALIS, INC.
Reel/Frame 019211/0197 →
Security Agreement Feb 8, 2010
From: ESSENTIALIS, INC.
To: STUART COLLINSON, FORWARD VENTURES V, L.P., AS COLLATERAL AGENT
Reel/Frame 023919/0840 →
Assignment of Assignor's Interest Sep 8, 2014
From: COWEN, NEIL M.; PASTERNAK, RICHARD C.
To: ESSENTIALIS, INC.
Reel/Frame 033692/0917 →
Assignment of Assignor's Interest Feb 13, 2015
From: COWEN, NEIL MADISON
To: ESSENTIALIS, INC.
Reel/Frame 034963/0118 →
Assignment of Assignor's Interest Nov 13, 2015
From: COWEN, NEIL M
To: ESSENTIALIS, INC.
Reel/Frame 037039/0755 →
Release of Security Interest Mar 3, 2017
From: ESSENTIALIS, INC.
To: STUART COLLINSON, FORWARD VENTURES V. L. P., AS COLLATERAL AGENT
Reel/Frame 041903/0902 →
Assignment of Assignor's Interest May 16, 2017
From: COWEN, NEIL M.; KASHKIN, KENNETH B.; YAMOUT, KHALED A.
To: ESSENTIALIS, INC.
Reel/Frame 042470/0486 →
Assignment of Assignor's Interest May 16, 2017
From: COWEN, NEIL M.; KASHKIN, KENNETH B.; YAMOUT, KHALED A.
To: ESSENTIALIS, INC.
Reel/Frame 042470/0446 →
Assignment of Assignor's Interest May 16, 2017
From: COWEN, NEIL M.; KASHKIN, KENNETH B.; YAMOUT, KHALED A.
To: ESSENTIALIS, INC.
Reel/Frame 042470/0234 →
Assignment of Assignor's Interest Aug 8, 2017
From: COWEN, NEIL M.
To: ESSENTIALIS, INC.
Reel/Frame 043235/0059 →
Assignment of Assignor's Interest Jul 20, 2018
From: COWEN, NEIL M.
To: ESSENTIALIS, INC.
Reel/Frame 046417/0565 →
Assignment of Assignor's Interest Feb 3, 2020
From: COWEN, NEIL M.
To: ESSENTIALIS, INC.
Reel/Frame 051702/0844 →
Assignment of Assignor's Interest Jun 16, 2020
From: COWEN, NEIL M.; KASHKIN, KENNETH B.; YAMOUT, KHALED A.
To: ESSENTIALIS, INC.
Reel/Frame 052956/0073 →
Assignment of Assignor's Interest Jun 15, 2021
From: COWEN, NEIL M.; KASHKIN, KENNETH B.; YAMOUT, KHALED A.
To: ESSENTIALIS, INC.
Reel/Frame 056554/0029 →
Assignment of Assignor's Interest Sep 20, 2023
From: COWEN, NEIL M.; YAMOUT, KHALED A.
To: ESSENTIALIS, INC.
Reel/Frame 064969/0854 →
Assignment of Assignor's Interest Mar 6, 2024
From: COWEN, NEIL M.
To: ESSENTIALIS, INC.
Reel/Frame 066673/0322 →
Assignment of Assignor's Interest Sep 27, 2024
From: COWEN, NEIL M.
To: ESSENTIALIS, INC.
Reel/Frame 068728/0892 →
Security Interest Dec 17, 2024
From: SOLENO THERAPEUTICS, INC.; ESSENTIALIS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 069613/0369 →
Assignment of Assignor's Interest Mar 5, 2025
From: COWEN, NEIL M.
To: ESSENTIALIS, INC.
Reel/Frame 070416/0021 →
Amended and Restated Intellectual Property Security Agreement Mar 12, 2025
From: SOLENO THERAPEUTICS, INC.; ESSENTIALIS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 070494/0042 →
Assignment of Assignor's Interest Dec 3, 2025
From: ESSENTIALIS, INC.
To: SOLENO THERAPEUTICS, INC.
Reel/Frame 073832/0312 →
Security Interest Jun 26, 2026
From: SOLENO THERAPEUTICS, INC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 075106/0487 →